OMP begins first human trial of self-expanding hydrogel capsule SironaOxford Medical Products (OMP) has initiated the first human trial of Sirona, its self-expanding hydrogel capsule which aims to deliver a...
Oxford Medical Products gains £2.5 million funding for weight-loss hydrogel technologyOxford Medical Products has raised £2.5M in equity investment to conduct the first human trials of Sirona, its weight-loss platform....
Key factors that can impact long-term weight loss in patients with obesity prescribed GLP-1 RA medications4 days ago